University Hospital, Toulouse: Parkinson Disease trials
The registry lists 34 Parkinson Disease studies with University Hospital, Toulouse as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 2 6Phase 3 3Phase 4 1No phase 25(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effect of Botulinum Toxin on Resting Tremor of the Refractory Upper Limb in ParkinsoniansNot yet recruitingNCT07822893Phase 3
- Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot StudyNot yet recruitingNCT07578272Not applicable
- AI-based Progression and Medication Response Prediction Study in Parkinson's DiseaseNot yet recruitingNCT07189468
- Detection of Internal Tremors by Oscillometry in Parkinson's PatientRecruitingNCT06885541Not applicable
- The Effect of Amantadine As Add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled TrialNot yet recruitingNCT06817200Phase 2
- AI-PROGNOSIS - Digital Biomarkers Development Study (dBM-DEV)Not yet recruitingNCT06444789
- Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)RecruitingNCT06008704Not applicable
- Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's DiseaseCompletedNCT06080399
- O-ARM Stereotactic Imaging in Deep Brain Stimulation for Parkinson's DiseaseCompletedNCT05910008Not applicable
- Describe to Better Understand, the Mealtime of People With Parkinson's Disease Dependent on Food IntakeCompletedNCT05898139
- Comparative Study of Personality in Parkinson's Disease Patients With Other Chronic PainCompletedNCT05713500
- Combined Deep Brain Stimulation in Parkinson's DiseaseCompletedNCT05415774Not applicable
- Integrated Parkinson Care Networks : Care in Parkinson DiseaseStatus unknownNCT04915209Not applicable
- Foot Reflexology on Chronic Pain in Parkinsonian PatientsCompletedNCT04705207Not applicable
- Integrated Parkinson Care Networks: Assessment of Economics and Socials BarriersCompletedNCT04485468
- Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson PatientsCompletedNCT04466839
- Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)CompletedNCT04228523Not applicable
- Primary Parkinsonian Pain Diagnostic Questionnaire: Development and Validation of This QuestionnaireCompletedNCT03940872Not applicable
- Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's DiseaseStatus unknownNCT03793491
- Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's DiseaseCompletedNCT03439943Phase 2
- Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's DiseaseCompletedNCT02601586Phase 2/3
- Transcutaneous Electrical Nerve Stimulation (TENS) for Lower Urinary Tract Disorders in Parkinson's SyndromeCompletedNCT02190851Not applicable
- Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other SynucleinopathiesCompletedNCT02021903Not applicable
- Words Generation in Compulsives Gamblers and Parkinson's Disease PatientsCompletedNCT01888276Not applicable
- Motor Control During Rapid Eye Movement (REM) Sleep Behaviour DisorderTerminatedNCT01886131Not applicable
- Education in Therapy of Parkinson's DiseaseCompletedNCT01717144Not applicable
- Assessment of Three-dimensional Vision Alteration in Parkinson DiseaseCompletedNCT01620164Not applicable
- Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's DiseaseCompletedNCT01538329Phase 2
- Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's DiseaseCompletedNCT01504178Phase 3
- Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation in Pain Perception in Parkinson's DiseaseCompletedNCT01275573Phase 2
- Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) StudyCompletedNCT01044992Not applicable
- Dopaminergic Loss and Pain in Parkinson's DiseaseCompletedNCT00940914Phase 2
- Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)CompletedNCT00632762Phase 4
- Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging StudyCompletedNCT00524914Not applicable